Inventor · disambiguated record
Beat Imhof
Also filed as: IMHOF BEAT · IMHOF BEAT A · IMHOF BEAT ALBERT
18 granted patents·6 pending applications·47 citations·filing 1994–2023
92Inventor score
Top patents by PatentIndex Score
24 records- 0184US11492333B2Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancerUNIV BAR ILAN·Filed 2018·Granted Nov 8, 2022·3 cites·23 claims
- 0283US7642341B2Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancerMERCK SERONO SA·Filed 2003·Granted Jan 5, 2010·8 cites·26 claims
- 0382US10385129B2JAM-C antibodies and methods for treatment of cancerRES FOUND DEV·Filed 2017·Granted Aug 20, 2019·2 cites·7 claims
- 0478US8093010B2Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancerIMHOF BEAT A·Filed 2009·Granted Jan 10, 2012·3 cites·12 claims
- 0576US7670826B2Confluence regulated adhesion molecules useful in modulating vascular permeabilityMERCK SERONO SA·Filed 2008·Granted Mar 2, 2010·2 cites·22 claims
- 0674US12252472B1Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancerUNIV BAR ILAN·Filed 2022·Granted Mar 18, 2025·0 cites·28 claims
- 0774US12240820B2Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancerUNIV BAR ILAN·Filed 2023·Granted Mar 4, 2025·0 cites·15 claims
- 0874US8007797B2Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their useMERCK SERONO SA·Filed 2007·Granted Aug 30, 2011·3 cites·17 claims
- 0973US7790863B2Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancerMERCK SERONO SA·Filed 2004·Granted Sep 7, 2010·7 cites·14 claims
- 1072US9803014B2JAM-C antibodies and methods for treatment of cancerRES DEV FOUNDATION·Filed 2013·Granted Oct 31, 2017·2 cites·12 claims
- 1172US9096662B2Methods and compositions for modulation of Olfml3 mediated angiogenisisRES DEV FOUNDATION·Filed 2014·Granted Aug 4, 2015·2 cites·6 claims
- 1266US7393651B2Confluence regulated adhesion molecules useful in modulating vascular permeabilitySERONO LAB·Filed 2004·Granted Jul 1, 2008·2 cites·30 claims
- 1364US10759857B2JAM-C antibodies and methods for treatment of cancerRES FOUND DEV·Filed 2018·Granted Sep 1, 2020·0 cites·12 claims
- 1464US8663637B2Methods and compositions for modulation of Olfml3 mediated angiogenesisIMHOF BEAT A·Filed 2012·Granted Mar 4, 2014·1 cites·15 claims
- 1557US2011052677A1Modulation of srpx2-mediated angiogenesisRES DEV FOUNDATION·Filed 2009·Application pending·0 cites
- 1654US5538725AMethod of inhibiting metastasis by anti-α6-integrin-antibodiesHOFFMANN LA ROCHE·Filed 1994·Granted Jul 23, 1996·12 cites·3 claims
- 1749US2018214546A1Modulation of srpx2-mediated angiogenesisRES FOUND DEV·Filed 2018·Application pending·0 cites
- 1849US2016333084A1Methods and compositions for modulation of olfml3 mediated angiogenesisRES DEV FOUNDATION·Filed 2016·Application pending·0 cites
- 1948US2013084296A1Modulation of srpx2-mediated angiogenesisRES DEV FOUNDATION·Filed 2012·Application pending·0 cites
- 2046US2015299306A1Methods and compositions for modulation of olfml3 mediated angiogenesisRES DEV FOUNDATION·Filed 2015·Application pending·0 cites
- 2145US8143056B2Vascular adhesion molecules and modulation of their functionIMHOF BEAT ALBERT·Filed 2010·Granted Mar 27, 2012·0 cites·11 claims
- 2245US2011287088A1Modulation of olfml-3 mediated angiogenesisIMHOF BEAT A·Filed 2009·Application pending·0 cites
- 2344US10808026B2Monoclonal Olfml-3 antibodies and uses thereofRES FOUND DEV·Filed 2014·Granted Oct 20, 2020·0 cites·15 claims
- 2433US7033794B2Basolateral sorting signal and inhibitors thereofUNIV GENEVE·Filed 2002·Granted Apr 25, 2006·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Beat Imhof files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →